The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 28, 2020

Filed:

Jan. 19, 2018
Applicants:

Geneuro SA, Plan-les-Ouates, CH;

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Hervé Perron, Saint Genis les Ollieres, FR;

Julie Medina, Lentilly, CH;

Avindra Nath, Silver Spring, MD (US);

Joseph Perry Steiner, Mounty Airy, MD (US);

Wenxue Li, Rockville, MD (US);

Myound-Hwa Lee, Silver Spring, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); A61K 49/00 (2006.01); A61K 49/16 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); C12P 21/08 (2006.01); C07K 16/00 (2006.01); A61K 38/17 (2006.01); C07K 14/47 (2006.01); C07K 16/10 (2006.01); G01N 33/68 (2006.01); A61P 31/22 (2006.01); A61P 25/02 (2006.01); A61P 25/28 (2006.01); A61P 31/20 (2006.01); A61P 25/00 (2006.01); A61P 31/14 (2006.01); A61P 21/00 (2006.01); A61P 31/12 (2006.01); G01N 33/563 (2006.01); G01N 33/569 (2006.01); A61P 31/00 (2006.01); A61P 25/14 (2006.01); A61K 39/42 (2006.01); A61K 39/245 (2006.01); A61K 39/12 (2006.01); A61K 39/15 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1036 (2013.01); G01N 33/6896 (2013.01); A61K 39/12 (2013.01); A61K 39/15 (2013.01); A61K 39/245 (2013.01); A61K 39/395 (2013.01); A61K 39/42 (2013.01); A61K 2039/505 (2013.01); A61K 2039/525 (2013.01); A61K 2039/60 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6075 (2013.01); A61K 2121/00 (2013.01); A61P 21/00 (2018.01); A61P 25/00 (2018.01); A61P 25/02 (2018.01); A61P 25/14 (2018.01); A61P 25/28 (2018.01); A61P 31/00 (2018.01); A61P 31/12 (2018.01); A61P 31/14 (2018.01); A61P 31/20 (2018.01); A61P 31/22 (2018.01); C07K 2317/00 (2013.01); C07K 2317/10 (2013.01); C07K 2317/34 (2013.01); C07K 2317/50 (2013.01); C07K 2317/62 (2013.01); C07K 2317/622 (2013.01); C07K 2317/624 (2013.01); C07K 2317/64 (2013.01); C07K 2317/66 (2013.01); C07K 2317/70 (2013.01); C07K 2317/76 (2013.01); C12N 2320/00 (2013.01); C12N 2320/50 (2013.01); C12N 2710/00011 (2013.01); C12N 2710/00022 (2013.01); C12N 2710/16011 (2013.01); C12N 2710/16122 (2013.01); C12N 2740/10011 (2013.01); C12N 2740/10022 (2013.01); C12Q 2600/158 (2013.01); G01N 33/53 (2013.01); G01N 33/563 (2013.01); G01N 33/569 (2013.01); G01N 2333/15 (2013.01); G01N 2469/00 (2013.01); G01N 2469/10 (2013.01); G01N 2800/00 (2013.01); G01N 2800/28 (2013.01); G01N 2800/285 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract

The present invention relates to a novel antibody against HERV-K envelope that targets a conserved region not affected by glycosylation or by native conformation, and its use in diagnostics and/or in therapy.


Find Patent Forward Citations

Loading…